A Virus to Fight Addiction

Perhaps a nose-full of virus can fight cocaine addiction. Researchers at the Scripps Research Institute in La Jolla, Calif., report that a bacteriophage with anticocaine antibodies can be used to block or sequester cocaine in the brain.1 Chemist Kim Janda and colleagues injected the antibody-displaying phages nasally, finding that treated rats moved less and showed reduced rearing and sniffing when injected with cocaine.Other attempts to block cocaine have used antibodies in the blood stream, bu

Written byHarvey Black
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Perhaps a nose-full of virus can fight cocaine addiction. Researchers at the Scripps Research Institute in La Jolla, Calif., report that a bacteriophage with anticocaine antibodies can be used to block or sequester cocaine in the brain.1 Chemist Kim Janda and colleagues injected the antibody-displaying phages nasally, finding that treated rats moved less and showed reduced rearing and sniffing when injected with cocaine.

Other attempts to block cocaine have used antibodies in the blood stream, but Janda wanted to see if they could work in the brain. "That's where all the action goes on with regards to addiction," he says. The viral treatment was most successful at lower cocaine doses.

This method is a novel approach, notes Kathleen Kantak, a Boston University neuroscientist. But she does have a reservation: "It was a little disappointing. The effects of the antibody were very short-lived; it was able to block the locomotor stimulatory ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies